Advertisement
Advertisement
BIO
Bio-Rad Laboratories, Inc.Class A
326.72
USDSponsored
-0.53
-0.16%
Jul 30, 15:59 UTC -4
Closed
Pre-Market
327.99
+1.26
+0.39%
BIO Earnings Reports
Positive Surprise Ratio
BIO beat 29 of 42 last estimates.
69%
Next Report
Next Week
Date of Next Report
Aug 04, 2026
Estimate for Q2 26 (Revenue/ EPS)
$630.23M
/$1.76
Implied change from Q1 26 (Revenue/ EPS)
+6.44%
/-6.88%
Implied change from Q2 25 (Revenue/ EPS)
-3.28%
/-32.57%
Bio-Rad Laboratories, Inc.Class A earnings per share and revenue
On Apr 30, 2026, BIO reported earnings of 1.89 USD per share (EPS) for Q1 26, missing the estimate of 2.00 USD, resulting in a -5.68% surprise. Revenue reached 592.10 million, compared to an expected 594.76 million, with a -0.45% difference. The market reacted with a -8.41% price change (close before vs. close after earnings).
Looking ahead to Q2 26, 6 analysts forecast an EPS of 1.76 USD, with revenue projected to reach 630.23 million USD, implying an decrease of -6.88% EPS, and increase of 6.44% in Revenue from the last quarter.
Industry Peers’ Earnings
Industry Peers' Earnings displays EPS earnings data from companies in the same industry. Click on a card to view more details.
Baxter International Inc.
Report Date
Jul 30, 2026 For Q2 26
Estimate
$0.36
Actual
$0.56
Surprise
+52.17%
Stryker Corporation
Report Date
Jul 30, 2026 For Q2 26
Estimate
$3.52
Actual
$3.69
Surprise
+4.76%
Boston Scientific Corp.
Report Date
Jul 29, 2026 For Q2 26
Estimate
$0.83
Actual
$0.86
Surprise
+2.97%
GE HealthCare Technologies Inc. Common Stock
Report Date
Jul 29, 2026 For Q2 26
Estimate
$1.05
Actual
$1.12
Surprise
+7.03%
KONINKLIJKE PHILIPS N.V.
Report Date
Jul 28, 2026 For Q2 26
Estimate
$0.35
Actual
$0.50
Surprise
+40.01%
AtriCure, Inc.
Report Date
Jul 23, 2026 For Q2 26
Estimate
$0.00
Actual
$0.18
Surprise
+3,900.00%
Tilray Brands, Inc. Common Stock
Report Date
Jul 28, 2026 For Q4 26
Estimate
-$0.01
Actual
-$0.43
Surprise
-3,061.76%
Cerus Corp
Report Date
Jul 30, 2026 For Q2 26
Estimate
-$0.01
Actual
-$0.01
Surprise
+26.47%
Sundial Growers Inc. Common Shares
Report Date
Jul 28, 2026 For Q2 26
Estimate
$0.00
Actual
-$0.02
Surprise
-453.29%
FAQ
What were Bio-Rad Laboratories, Inc.Class A's earnings and revenue for the latest quarter Q1 2026?
For Q1 2026, Bio-Rad Laboratories, Inc.Class A reported EPS of $1.89, missing estimates by -5.68%, and revenue of $592.10M, -0.45% below expectations.
How did the market react to Bio-Rad Laboratories, Inc.Class A's Q1 2026 earnings?
The stock price moved down -8.41%, changed from $280.12 before the earnings release to $256.55 the day after.
When is Bio-Rad Laboratories, Inc.Class A expected to report next?
The next earning report is scheduled for Aug 04, 2026.
What are the forecasts for Bio-Rad Laboratories, Inc.Class A's next earnings report?
Based on 6
analysts, Bio-Rad Laboratories, Inc.Class A is expected to report EPS of $1.76 and revenue of $630.23M for Q2 2026.
Which companies are reporting earnings today?
Check FXEmpire's Earnings Calendar for today's list of reporting companies.
Advertisement